BENFW

Beneficient Warrants represent the right to purchase shares of Beneficient common stock at a predetermined exercise price during a specified time period. These warrants were issued as part of previous financing transactions and provide holders with leveraged exposure to Beneficient's business prospects. The warrants trade separately from the common stock and appeal to investors seeking amplified participation in potential appreciation of Beneficient's equity value as the company scales its alternative asset liquidity solutions business. As derivative securities, the warrants' value derives from the underlying Beneficient common stock price. When the stock price exceeds the warrant's exercise price, the warrants possess intrinsic value equal to the difference. Additionally, warrants carry time value based on the remaining exercise period and the stock's expected volatility. This leverage characteristic enables warrants to deliver larger percentage gains than the underlying stock during appreciation periods, though they also carry higher risk and can decline more sharply during downturns. Beneficient operates a unique business model providing liquidity solutions for investors holding interests in alternative assets such as private equity, venture capital, and hedge funds. The company's ExchangeTrust platform and collateralized lending products address the substantial market need for liquidity in the multi-trillion-dollar alternative investment market. Successful execution of Beneficient's business plan, transaction volume growth, regulatory developments, strategic partnerships, or other positive business milestones could drive stock price appreciation, creating value for warrant holders. These instruments suit investors with higher risk tolerance who believe in Beneficient's innovative approach to unlocking value from illiquid alternative assets. If the stock price remains below the exercise price at expiration, the warrants expire worthless.